PROMISE-AD: Progression-aware Multi-horizon Survival Estimation for Alzheimer's Disease Progression and Dynamic Tracking

arXiv cs.LG / 5/1/2026

📰 NewsIdeas & Deep AnalysisModels & Research

Key Points

  • PROMISE-AD is a new leakage-safe, multi-horizon survival framework designed to predict individualized Alzheimer’s disease conversion risks while handling irregular visits and censoring using ADNI/TADPOLE tabular histories.
  • The model transforms pre-index visits into tokenized representations that include standardized measurements, missingness masks, longitudinal changes, time-normalized slopes, visit timing, and non-diagnostic categorical attributes to avoid diagnostic leakage.
  • A temporal Transformer fuses multiple temporal views (global, attention-pooled, and latest-visit) and estimates progression using latent discrete-time mixture hazards.
  • Training uses a combination of survival likelihood, horizon-specific focal risk losses, progression ranking, hazard smoothness, and mixture-balance regularization, followed by isotonic calibration for 1-, 2-, 3-, and 5-year risks.
  • Reported results on held-out testing show strong performance for CN-to-MCI conversion (best integrated Brier score among compared methods) and very high discrimination for MCI-to-AD conversion, with ablations and interpretability supporting the usefulness of longitudinal change features and mixture-hazard modeling.

Abstract

Individualized Alzheimer's disease (AD) progression prediction requires models that use irregular visits, account for censoring, avoid diagnostic leakage, and provide calibrated horizon risks. We propose PROgression-aware MultI-horizon Survival Estimation for Alzheimer's Disease (PROMISE-AD), a leakage-safe survival framework for predicting conversion from cognitively normal (CN) to mild cognitive impairment (MCI) and from MCI to AD dementia using ADNI/TADPOLE tabular histories. PROMISE-AD converts pre-index visits into tokens with standardized measurements, missingness masks, longitudinal changes, time-normalized slopes, visit timing, and non-diagnostic categorical attributes. A temporal Transformer fuses global, attention-pooled, and latest-visit representations to estimate a progression score and latent discrete-time mixture hazards. Training combines survival likelihood, horizon-specific focal risk loss, progression ranking, hazard smoothness, and mixture-balance regularization, followed by validation-set isotonic calibration for 1-, 2-, 3-, and 5-year risks. In held-out testing across three seeds, PROMISE-AD achieved an integrated Brier score (IBS) of 0.085 \pm 0.012, C-index of 0.808 \pm 0.015, and mean time-dependent AUC of 0.840 \pm 0.081 for CN-to-MCI conversion, yielding the lowest IBS among compared methods. For MCI-to-AD conversion, PROMISE-AD achieved the highest C-index (0.894 \pm 0.018) and near-ceiling 5-year discrimination (AUROC 0.997 \pm 0.003; AUPRC 0.999 \pm 0.001), although some baselines had lower IBS. Ablations and interpretability supported longitudinal change features, fused temporal representations, mixture hazards, cognitive and functional measures, APOE4 status, and recent conversion-proximal visits. These findings suggest that progression-aware survival modeling can provide interpretable multi-horizon AD conversion risk estimates.